Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]

JN George, SH Woolf, GE Raskob, JS Wasser, LM Aledort, PJ Ballem, VS Blanchette, JB Bussel, DB Cines, JG Kelton, AE Lichtin, R McMillan, JA Okerbloom, DH Regan, I Warrier

Blood (1996) 88 (1): 3–40.

https://doi.org/10.1182/blood.V88.1.3.3

Published: 1996

Journal Articles

A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin

RS Schwartz, DA Gabriel, LM Aledort, D Green, CM Kessler

Blood (1995) 86 (2): 797–804.

https://doi.org/10.1182/blood.V86.2.797.bloodjournal862797

Published: 1995

Journal Articles

Immune status of human immunodeficiency virus seropositive and seronegative hemophiliacs infused for 3.5 years with recombinant factor VIII. The Kogenate Study Group

PM Mannucci, DB Brettler, LM Aledort, JM Lusher, CF Abildgaard, RS Schwartz, D Hurst

Blood (1994) 83 (7): 1958–1962.

https://doi.org/10.1182/blood.V83.7.1958.1958

Published: 1994

Journal Articles

Effect on lymphocyte subsets of clotting factor therapy in human immunodeficiency virus-1-negative congenital clotting disorders. The Transfusion Safety Study Group

J Hassett, GF Gjerset, JW Mosley, MA Fletcher, E Donegan, JW Parker, RB Counts, LM Aledort, H Lee, MC Pike

Blood (1993) 82 (4): 1351–1357.

https://doi.org/10.1182/blood.V82.4.1351.1351

Published: 1993

Journal Articles

Acquired immunodeficiency syndrome-associated non-Hodgkin's lymphomas and other malignancies in patients with hemophilia

MV Ragni, SH Belle, RA Jaffe, SL Duerstein, DC Bass, CW McMillan, EW Lovrien, LM Aledort, CT Kisker, SP Stabler

Blood (1993) 81 (7): 1889–1897.

https://doi.org/10.1182/blood.V81.7.1889.1889

Published: 1993

Journal Articles

Human immunodeficiency virus-related conditions in children and adults with hemophilia: rates, relationship to CD4 counts, and predictive value

ME Eyster, CS Rabkin, MW Hilgartner, LM Aledort, MV Ragni, J Sprandio, GC White, S Eichinger, P de Moerloose, WA Andes

Blood (1993) 81 (3): 828–834.

https://doi.org/10.1182/blood.V81.3.828.828

Published: 1993

Journal Articles

Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect [see comments]

JB Bussel, JN Graziano, RP Kimberly, S Pahwa, LM Aledort

Blood (1991) 77 (9): 1884–1893.

https://doi.org/10.1182/blood.V77.9.1884.1884

Published: 1991

Journal Articles

A codon 338 nonsense mutation in the factor IX gene in unrelated hemophilia B patients: factor IX338 New York

MC Driscoll, E Bouhassira, LM Aledort

Blood (1989) 74 (2): 737–742.

https://doi.org/10.1182/blood.V74.2.737.737

Published: 1989

Journal Articles

A second BamHI DNA polymorphism and haplotype association in the factor IX gene

MC Driscoll, A Dispenzieri, E Tobias, CH Miller, LM Aledort

Blood (1988) 72 (1): 61–65.

https://doi.org/10.1182/blood.V72.1.61.61

Published: 1988

Journal Articles

Discriminant analysis for probability of hemophilia A carriership [letter]

CH Miller, LM Aledort

Blood (1987) 69 (2): 704–705.

https://doi.org/10.1182/blood.V69.2.704.704

Published: 1987

Journal Articles

Long-term follow-up of hemophiliacs with lymphocytopenia or thrombocytopenia

ME Eyster, DA Whitehurst, PM Catalano, CW McMillan, SH Goodnight, CK Kasper, JC Gill, LM Aledort, MW Hilgartner, PH Levine

Blood (1985) 66 (6): 1317–1320.

https://doi.org/10.1182/blood.V66.6.1317.1317

Published: 1985

Journal Articles

A study of liver biopsies and liver disease among hemophiliacs

LM Aledort, PH Levine, M Hilgartner, P Blatt, JA Spero, JD Goldberg, L Bianchi, V Desmet, P Scheuer, H Popper

Blood (1985) 66 (2): 367–372.

https://doi.org/10.1182/blood.V66.2.367.367

Published: 1985

Journal Articles

Autoplex versus proplex: a controlled, double-blind study of effectiveness in acute hemarthroses in hemophiliacs with inhibitors to factor VIII

JM Lusher, PM Blatt, JA Penner, LM Aledort, PH Levine, GC White, AI Warrier, DA Whitehurst

Blood (1983) 62 (5): 1135–1138.

https://doi.org/10.1182/blood.V62.5.1135.1135

Published: 1983

NARROW

Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]

A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin

Immune status of human immunodeficiency virus seropositive and seronegative hemophiliacs infused for 3.5 years with recombinant factor VIII. The Kogenate Study Group

Effect on lymphocyte subsets of clotting factor therapy in human immunodeficiency virus-1-negative congenital clotting disorders. The Transfusion Safety Study Group

Acquired immunodeficiency syndrome-associated non-Hodgkin's lymphomas and other malignancies in patients with hemophilia

Human immunodeficiency virus-related conditions in children and adults with hemophilia: rates, relationship to CD4 counts, and predictive value

Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect [see comments]

A codon 338 nonsense mutation in the factor IX gene in unrelated hemophilia B patients: factor IX338 New York

A second BamHI DNA polymorphism and haplotype association in the factor IX gene

Discriminant analysis for probability of hemophilia A carriership [letter]

Long-term follow-up of hemophiliacs with lymphocytopenia or thrombocytopenia

A study of liver biopsies and liver disease among hemophiliacs

Autoplex versus proplex: a controlled, double-blind study of effectiveness in acute hemarthroses in hemophiliacs with inhibitors to factor VIII

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only